Javier Zambrano, MD

AbbVie, Inc.

Poster(s):

• D0383 - Baseline and Early Predictors of Response to Risankizumab Induction and Maintenance Treatment in Patients With Moderate to Severe Crohn's Disease
  Tuesday, October 25, 2022

  10:00 AM – 12:00 PM ET